NCT05270824View on ClinicalTrials.gov

Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2027

Conditions
Advanced Gastric CarcinomaCD8+ Tumor Infiltrating LymphocytesNeoadjuvant Immunotherapy
Interventions
COMBINATION_PRODUCT

radical surgery after neoadjuvant immunotherapy

A total or distal gastrectomy with D2 lymph node dissection was done depending on the tumor location after neoadjuvant immunotherapy.

COMBINATION_PRODUCT

radical surgery after neoadjuvant chemotherapy

A total or distal gastrectomy with D2 lymph node dissection was done depending on the tumor location after neoadjuvant immunotherapy.

All Listed Sponsors
lead

Fujian Medical University

OTHER